CT-2584
CT-2584 is an anticancer agent that inhibits phospholipid signaling and kills tumor cells through the production of reactive oxygen intermediates. CT-2584 reduces NKEF-B expression in several tumor cell types. CT-2584 reduced tumor growth in SCID mice by causing shunting of ab initio phospholipid biosynthesis from phosphatidylcholine (PC) to phosphatidylinositol (PI) via PA.
Product Specifications
CAS Number
166981-13-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
533.79
Molecular Formula
C30H55N5O3
Notes
Research use only, not for human use.
Receptor
Reactive Oxygen Species
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6465055-01 0.2 mL
BLNK, ID (B Cell Linker Protein, Cytoplasmic Adapter Protein, B Cell Adapter Containing a SH2 Domain Protein, B Cell Adapter Containing a Src Homology 2 Domain Protein, Src Homology 2 Domain-containing Leukocyte Protein of 65kD, SLP-65, SLP65, BASH, BLNK)
Ask
View Details 
MBS6465055-02 5x 0.2 mL
BLNK, ID (B Cell Linker Protein, Cytoplasmic Adapter Protein, B Cell Adapter Containing a SH2 Domain Protein, B Cell Adapter Containing a Src Homology 2 Domain Protein, Src Homology 2 Domain-containing Leukocyte Protein of 65kD, SLP-65, SLP65, BASH, BLNK)
Ask
View Details 
043327-HRP 200 µL
TSC1, phosphorylated (T310) (TSC1, KIAA0243, TSC, Hamartin, Tuberous sclerosis 1 protein) (Azide free) (HRP) discontinued
Ask
View Details